The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action
- 1 August 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 166 (3), 493-504
- https://doi.org/10.1016/0014-2999(89)90363-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biochemical and Pharmacological Characterization of [3H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake ComplexJournal of Neurochemistry, 1987
- The Benzazepine, SCH 23390, Inhibits 3H‐NPA Binding in Mouse Brain In VivoActa Pharmacologica et Toxicologica, 1986
- Characterization of Sodium‐Dependent [3H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport ComplexJournal of Neurochemistry, 1986
- GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivoEuropean Journal of Pharmacology, 1986
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Neurochemical Profile of Lu 19‐005, a Potent Inhibitor of Uptake of Dopamine, Noradrenaline, and SerotoninJournal of Neurochemistry, 1985
- Sodium‐Sensitive Cocaine Binding to Rat Striatal Membrane: Possible Relationship to Dopamine Uptake SitesJournal of Neurochemistry, 1983
- Saturable (3H)cocaine binding in central nervous system of mouseLife Sciences, 1980
- An inhibitor of dopamine uptake, LR5182, CIS-3-(3,4-dichlorophenyl)-2-N, N-dimethylaminomethyl-bicyclo-[2,2,2]-octane, hydrochlorideLife Sciences, 1978
- Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depressionPsychopharmacology, 1977